Eledon Pharmaceuticals, Inc.·4

May 2, 6:50 PM ET

Perrin Steven 4

4 · Eledon Pharmaceuticals, Inc. · Filed May 2, 2023

Insider Transaction Report

Form 4
Period: 2023-05-01
Perrin Steven
DirectorPresident
Transactions
  • Award

    Stock Option (right to buy)

    2023-05-01+317,147317,147 total
    Exercise: $2.30Exp: 2033-05-01Common Stock (317,147 underlying)
Footnotes (1)
  • [F1]This option represents a right to purchase up to 317,147 shares of Common Stock, which option vests with respect to 79,287 shares on May 1, 2024, and then with respect to 6.25% of the underlying shares quarterly over the three-year period ending May 1, 2027.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION